期刊文献+

获得性凝血因子Ⅹ缺乏症三例报告并文献复习 被引量:3

Acquired coagulation factor Ⅹ deficiency: three cases report and literature review
原文传递
导出
摘要 目的 加深对获得性凝血因子Ⅹ缺乏症的认识.方法 对3例获得性凝血因子Ⅹ缺乏症患者的临床资料进行分析,并复习相关文献.结果 例1,男,57岁,诊断为多发性骨髓瘤轻链型、继发性淀粉样变、获得性凝血因子Ⅹ缺乏症,表现为自发性皮肤黏膜出血,凝血因子Ⅹ活性(FⅩ∶C)1.8%,予以MP(马法兰+曲安西龙)方案联合沙利度胺及对症治疗,FⅩ∶C未见升高,因原发病进展死亡.例2,男,41岁,以颅内出血入院,FⅩ∶C 26.8%,予以补充叶酸、维生素B12、维生素K,并输注红细胞、血小板及新鲜冰冻血浆治疗,颅内出血好转.例3,女,63岁,因反复发作四肢关节出血4个月入院,FⅩ∶C 6.1%,给予凝血酶原复合物、甲泼尼龙、硫唑嘌呤、利妥昔单抗治疗,FⅩ∶C未见明显升高,关节腔出血仍反复发作.结论 获得性凝血因子Ⅹ缺乏症临床表现具有异质性,诊断依赖病史和实验室检查,治疗包括控制出血和治疗原发病,预后与患者基础疾病相关. Objective To deepen the understanding of acquired coagulation factor Ⅹ (F Ⅹ) deficiency.Methods The clinical data of 3 patients were analyzed and related literature were reviewed.Results Case 1,a 57-year-old male,secondary to multiple myeloma and amyloidosis,was presented with spontaneous mucous hemorrhage with the level of F Ⅹ ∶ C 1.8%,which kept unchanged after chemotherapy with melphalan,glucocorticoid,and thalidomide,and died of primary disease progression.Case 2,a 41-year-old male with psoriasis,was presented with cerebral and retinal hemorrhage with the level of F Ⅹ ∶ C 26.8%.The signs of hemorrhage were alleviated after the supplement of folic acid,vitamin B12,and vitamin K,and transfusion with red blood cells,platelets,and fresh frozen plasma.Case 3,a 63-year-old female,associated with high level of lupus anticoagulant,was presented with repeated ecchymosis and haemarthrosis with the level of F Ⅹ ∶C 6.1%,which was refractory to prothrombin complex concentrate,methyprednisolone,azathioprine,and rituximab.Conclusions Acquired F Ⅹ deficiency is a rare disorder with variable symptoms.The diagnosis relies on history of disease and laboratory test.Currently,there is no standardized treatment.The prognosis of acquired F Ⅹ deficiency is mainly related to the underlying disease.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2014年第7期633-636,共4页 Chinese Journal of Hematology
基金 天津市应用基础及前沿技术研究计划(12JCQN-JC08000)
关键词 因子Ⅹ缺乏 多发性骨髓瘤 颅内出血 治疗结果 Factor Ⅹ deficiency Multiple myeloma Intracranial hemorrhages Treatment outcome
  • 相关文献

参考文献14

  • 1Uprichard J, Perry DJ. Factor X deficiency[J]. Blood Rev, 2002,16(2):97-110.
  • 2Dewerchin M, Liang Z, Moons L, et al. Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice [J]. Thromb Haemost, 2000, 83 (2): 185-190.
  • 3Lee G, Duan-Porter W, Metjian AD. Acquired, non-amyloid related factor X deficiency: review of the literature [J]. Haemophilia, 2012, 18(5): 655-663.
  • 4Choufani EB, Sanchorawala V, Ernst T, et al. Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy[J]. Blood, 2001, 97(6): 1885-1887.
  • 5Mumford AD, O'donnell J, Gillmore JD, et al. Bleeding symp- toms and coagulation abnormalities in 337 patients with AL- amyloidosis [J]. Br J Haematol, 2000, 110(2): 454-460.
  • 6Furie B, Greene E, Furie BC. Syndrome of acquired factor X deficiency and systemic amyloidosis in vivo studies of the metabolic fate of factor X [J]. N Engl J Med, 1977, 297 (2): 81-85.
  • 7Ashrani AA, Aysola A, A1-Khatib H, et al. Lupus anticoagulant associated with transient severe factor X deficiency: a report of two patients presenting with major bleeding complications[J]. Br J Haematol, 2003, 121 (4): 639-642.
  • 8Menegatti M, Peyvandi F. Factor X deficiency [J]. Semin Thromb Hemost, 2009, 35 (4): 407-415.
  • 9杨艳辉,王宏梅,薛峰,刘晓帆,刘永泽,张磊,杨仁池.获得性凝血因子V抑制物患者三例报告并文献复习[J].中华血液学杂志,2012,33(4):294-298. 被引量:7
  • 10Henson K, Files JC, Morrison FS. Transient acquired factor X deficiency: report of the use of activated clotting concentrate to control a life-threatening hemorrhage [J]. Am J Med, 1989, 87 (5): 583-585.

二级参考文献25

  • 1Franchini M,Lippi G. Acquired factor V inhibitors:a systematic review[J].Journal of Thrombosis and Thrombolysis,2011.449-457.
  • 2HORDER MH. Isolated factor V deficiency caused by a specific inhibitor[J].Acta Haematologica,1955.235-241.
  • 3Streiff MB,Ness PM. Acquired FV inhibitors;a needless iatro-genic complication of bovine thrombin exposure[J].Transfusion,2002.18-26.
  • 4Knobl P,Lechner K. Acquired factor V inhibitors[J].Bailliere's Clinical Haematology,1998.305-318.
  • 5Kapur A,Kelsey PR,Isaacs PE. Factor V inhibitor in thrombosis[J].American Journal of Hematology,1993.384-388.
  • 6Koyama T,Saito T,Kusano T. Factor V inhibitor associated with Sj(o)gren' s syndrome[J].British Journal of Haematology,1995.893-896.
  • 7Kamphuisen PW,Haan J,RosekransPC. Deep-vein thrombosis and coumarin skin necrosis associated with a factor V inhibitor with lupus-like features[J].American Journal of Hematology,1998.176-178.
  • 8Kalafatis M,Simioni P,Tormene D. Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations[J].Blood,2002.3985-3992.
  • 9Ortel TL. Clinical and laboratory manifestations of anti-factor V antibodies[J].Journal of Laboratory and Clinical Medicine,1999.326-334.
  • 10Ang AL,Kuperan P,Ng CH. Acquired factor V inhibitor.A problem-based systematic review[J].Thrombosis and Haemostasis,2009.852-859.

共引文献6

同被引文献8

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部